Development of Validated Q-absorbance Ratio, Derivative Spectrophotometric and Stability indicating RP-HPLC methods for the simultaneous estimation of Losartan Potassium & Hydrochlorothiazide in Pharmaceutical Dosage Form and comparison of the results by ANOVA

[...]the authors attempted to develop new validated Q- absorbance ratio, Derivative spectrophotometric and Stability indicating RP-HPLC methods for the simultaneous estimation of Losartan Potassium and Hydrochlorothiazide in pharmaceutical dosage form. [...]the authors attempted not only to develop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research journal of pharmacy and technology 2019-06, Vol.12 (6), p.2687-2694
Hauptverfasser: Ashritha, V.V.S., Usharani, N., Alekhacharan, Soudamini, Alekhya, B., Venkatesh, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]the authors attempted to develop new validated Q- absorbance ratio, Derivative spectrophotometric and Stability indicating RP-HPLC methods for the simultaneous estimation of Losartan Potassium and Hydrochlorothiazide in pharmaceutical dosage form. [...]the authors attempted not only to develop new validated Q- absorbance ratio, Derivative spectroscopic and stability indicating RP-HPLC methods for the simultaneous estimation of Losartan Potassium and Hydrochlorothiazide in pharmaceutical dosage form but also to compare the results obtained using ANOVA. [...]the null hypothesis can be accepted indicating that there was no significant difference among the results obtained from the three proposed methods as shown in Table 11. [...]it can be concluded that any one of the developed methods can be used in the routine analysis of Losartan Potassium and Hydrochlorothiazide in combined tablet dosage forms depending upon the availability of instruments and materials.
ISSN:0974-3618
0974-360X
0974-306X
DOI:10.5958/0974-360X.2019.00449.9